Yaz Birth Control Side Effects

Litigation Update: Yaz, Yasmin, BeYaz, & Ocella Birth Control Litigation

Lawsuits have been filed against Bayer HealthCare Pharmaceutical for the birth control drug Yaz, Yasmin and Ocella. Yaz, Yasmin and Ocella birth control pills all contain drospirenone, a synthetic form of progestin which works in combination with ethinyl estradiol (estrogen) to prevent pregnancy. Drospirenone is not contained in other forms of birth control and is believed to be the major cause of side effects from Ocella, Yasmin and Yaz. Two recent case-control studies published in the British Medical Journal show that patients on the birth control pills containing drospirenone have a 200% higher risk of serious injury than those patients using first or second generation oral contraception. The New York Times recently published a major news story on the growing safety concerns with Yaz. Bayer manufactures and markets Yaz and Yasmin. Ocella, meanwhile, is a generic form of Yasmin. Bayer manufactures Ocella which is then packaged and sold by Barr Laboratories, which has recently been acquired by Teva Pharmaceuticals.

Yaz, Yasmin and Ocella

Resources News Videos Have you been injured by Yaz, Yasmin or Ocella?

Side effects of Yaz, Yasmin and Ocella may include:

• heart attacks
• strokes
• deep vein thrombosis
• pulmonary embolism
• blood clots in the legs and lungs
• cardiac arrhythmia
• kidney failure
• sudden death

The Judicial Panel on Multi-District Litigation has centralized all federal court cases involving Yaz/Yasmin/Ocella in the United States District Court for the Southern District of Illinois, MDL No. 2100.  The presiding District Court has appointed Levin, Papantonio shareholder Tim O'Brien to the Plaintiffs Steering Committee ("PSC") for the Yaz/Yasmin/Ocella MDL where he serves as co-chair of the Discovery Committee for the PSC.

If you or a loved one is suffering from an injury caused by Yaz, Yasmin or Ocella please contact us for a free evaluation.

Resources:

FDA Drug Safety Communication: Updated information about the risk of blood clots in women taking birth control pills containing drospirenone

News:

Bayer to pay 1.4 billion

Mom warns birth control killed her daughter

YAZ YASMIN LINKED TO IRRITABLE BOWEL SYNDROME

Washington Times Interviews Levin Papantonio Attorney Tim O'Brien About the Dangers of Yaz

The New York Times - Health Concerns Over Popular Contraceptives

British Medical Journal - The venous thrombotic risk of oral contraceptives, effects of oestrogen dose and progestogen type: results of the MEGA case-control study

British Medical Journal - Hormonal contraception and risk of venous thromboembolism: national follow-up study

FDA sends warning letter to Bayer Pharmaceutical over the birth control drug Yaz

FDA sends warning letter to Berlex Laboratories regarding the oral contraceptive Yasmin

Videos: